Member Info for lukehere

Hi polarhare. I thought that I was plowing a lone bullish furrow here,so its good to encounter some optimism. Potentially it is IBM who are trialing AuthorBridge.Whilst not yet released officially,there is much positive comment on this forthcoming enterprise DITA authoring solution among Stilo partners and in Content conversion related press releases. Once these conversions more generally move into the cloud, Stilo should start to benefit. The dividend alone(if maintained)produces a yield of over 2% at the current buy price. Almost risk free imo.

For those investors considering Stilo, the current availability of shares at 2.4 pence represents an excellent opportunity to acquire a stake. Make no mistake and seize the day, for the current downward trend in the SP will shortly reverse and the window will close. The picture of a moribund company that reported figures and a depressed share price currently paint could not be further from the truth. The company will soon present detail on its progress, potentially resulting in a much stronger SP performance. A VERY VERY "strong buy" imo.

Burgeoning pet sector sales,successful conclusion of NHS trials,marketing programme recently launched in European Union countries bearing fruit, satisfactory developments in the US for regulatory-approved access to the US domestic consumer markets;the list is endless. The corner for Byotrol has well and truly been turned. I think that the share price will settle at around 6 pence,reflecting these factors,prior to moving above 10 pence once the progress manifests itself by way of reported profitability. LOOKING GOOD !!

The shares will look incredibly cheap at around 4 pence once break even is achieved in 2015. The pet business alone underpins the current market cap. Load up, load up,whilst you can.

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/365875/MRRS_4101_Synoptics_ProReveal.pdf

All you need to research with Geong is the number of red flags . A possible way of making money here is through buying at sub 3 pence with a view to selling if the SP riese above 4 pence.It works for me although the threat of a belly up or de list is constantly there as a threat. Only for the reckless imo.

It would be great buying into BYOT at such a low level. If only the MMs would oblige and part with the shares,which,even at 3.5pence they are reluctant to do.

Thanks for your views. At 3 pence,surely the company becomes even more attractive as an investment. After all ,the CEO now has a clear sight of break even whilst their technology retains a clear and undiminished superiority.

At least the prelims do not constitute a "car crash",Dubuary. Would that I had bought all my BYOT shares @ 3.4pence;yet here they are available at that level. "They need to capture the public imagination with appropriate consumer products and competant marketing.... " How true. Catching that public attention is so ,so achievable. Your factors,a little luck,unexpected publicity,a major consumer deal,or possibly some type of relating health scare and Byotrol could/would emerge from relative obscurity.

Next week then for some clarity. Very very last chance to buy at these levels imo. "Strong Buy" is an understatement of my "opinion".

Carping clones, shark an cleaning,continue to hone their posting prowess. Sinsburys,"laughable",so they opine. Not so though. Already there in fact and positioned to expand it's presence. "With decades of experience and market leading knowledge of the pet sector, Petface are bringing a new generation of products to pet owners in the UK. Key to the Petface ethos is constant innovation and the commitment to provide only the most exciting products for pets and their owners. When selecting the right partner for their range of grooming and hygiene products, they chose Byotrol. Products are available now in Sainsbury’s stores nationwide and from all good pet stores, vets and garden centres.

"Byotrol’s novel capacity to sustain antimicrobial activity on skin and surfaces well after application is quite revolutionary. It really is a powerful message to anyone concerned with hygiene in the workplace." Dr. Peter Barratt PhD. CBiol MSB, Technical Manager,Rentokil Initial. (Initial has announced the launch of its UltraProtect range following a four year-long development process by partners Byotrol.The range is for use in commercial and public areas. It includes a new hand gel, foam hand sanitiser and handy packs of hand and surface wipes, offering employees a safe and convenient way to kill bacteria and other germs for longer. Exclusive to Initial, the UltraProtect range protects hands for up to six hours and surfaces for up to 24 hours between applications, unlike alcohol-based solutions, and kills a wide range of bacteria and viruses including swine flu (H1N1), MRSA, Salmonella, Norovirus and E. coli. The UltraProtect launch follows recent warnings by the Global Handwashing Day Coalition, (that includes Initial Washroom Hygiene), on poor hand hygiene levels in the UK.) As for the next supermarket;how about Sainsburys ?

I do not want to sound to repetitive but..... what a steal BYOT shares currently are,standing as they do at just 4.25 pence to buy. Ultra Protect from RI is now powering ahead across global markets,whilst serious inroads are now being into the massive NHS arena. The next big announcement,apart from the potential for profitable trading,could be news of another big supermarket chain not only stocking a range of Byotrol products,but also vigorously promoting them. BYOT is an overlooked and much derided share/company. Its time in the sun is however rapidly approaching. imo.

The past four years' outlook statements are published below. Note the explanation for the revenues drop. Note that 2014 is the first time that "rapidly expanding"is mentioned. Note that for the first time the Directors indicate that the benefits are being seen in the first two months trading. 2011 outlook statement The market for digital publishing technology and services is expanding as the use of the iPad, iPhone, eReaders, smartphones and tablet devices increases. This demand is driving the requirement for publishers to ensure their content is optimised for delivery across all these platforms. In addition, the adoption of the DITA standard by technology companies for technical documentation is accelerating. The flexibility and performance of our Stilo Migrate service puts us in a strong position to capitalise on these market trends. Additionally, we will seek to complement our publishing technology through the building of strategic relationships with offshore service providers, and to seek acquisition opportunities. Sales of SAP®-related services are expected to reduce in 2011 as our UK Defence customers face government budget cuts. We will be seeking to offset the impact of this, primarily with increased sales of our Product Change Impact Analysis tool to new customers in the UK and international markets. Overall, we look forward to growing the profitability of the company in 2011, and continuing the strategy of becoming primarily a technology supplier with a highly scalable business model. 2012 outlook statement Stilo had a cash balance of £939,000 as at 31 December 2011 (31 December 2010: £494,000). This significant improvement in the year-end cash position provides a stable financial base for the Company and will support continued investment in product development, sales and marketing. However, overall costs will continue to be carefully managed in order to maintain cash reserves at a satisfactory level. 2013 outlook statement With an expert development team, a global customer base, growing adoption of Migrate and a strong cash position, we look forward to making further progress in 2013." 2014 outlook statement The global market for dynamically publishing digital content to desktop computers, laptops, tablets and mobile devices is expanding rapidly. Trading in the two months of the current year has been in line with management forecasts. We look forward to continuing to build upon our leading position in the DITA XML content conversion market, and to press ahead with the development of new XML content processing solutions.

Their revenues turned lower as STL exited from SAP style commissions. I attend AGMs and CEO Les Burnham has ,year after year, opined that the world remained unready and unprepared to embrace fully STL technology and the benefits that it would deliver. It does look though as though Stilo is now starting to motor.Non recurring revenues increased by 15% over the past 6 months.They are beefing up the sales team,being highly recommended by a stream of global corporates and notable individuals whilst the Stilo web site has been transformed for the better. The rate of increase in annual revenues should now quicken appreciably ,with the very low overheads ensuring that any increase drops directly down to bottom line profit. The AGM is on May 15th, when I am anticipating that a positive outlook statement will be issued. The Chairman has added to his holding and no dilution is evident. The only reason the SP has dropped back from its multi year peak is that there is a persistent and aggressive seller around. Imo one should take advantage of this and BUY !!

Busicat. There are very few people who hold any interest or knowledge about STL,never mind investing in the company.What stimulated your decision to buy the shares?Are you involved at all in content conversion.? Revenues,excluding annual software maintenance contracts,actually rose by 15% last year.We could well see the rate of this growth at least double again in 2014 serving to generate a net profit of some £400k..Your 13 pence target then is most definitely achievable and in the meantime our investment is seemingly risk free. Happy days !

The phrase also grates with me Dubuary. Nevertheless,the TU does seem to be a step in the right direction. £700k synergies are pretty significant when compared to the recent level of losses reported. I take the view that any impending upward movement in the share price will not,on this occasion,be so swiftly reversed.

I have followed STL for several years,attending AGMs and speaking with the BOD. My view is that there is tremendous scope to grow this company away from its micro cap status. A 10% increase in current year revenues could see EBITDA doubling again to over £500k. The ONLY reason,imo,that STL has such an unmerited lowly SP is the seller who is intent on ditching his holding. Just as soon as the overhang clears we could well see a double figure share price. Keep buying.I am.

Byotrol's B.toB. division continues to thrive whilst revenues are at long last demonstrating more visible improvement. The Karrimor Range is due on Lillywhites shelves as from this September. Not too long then before Byotrol announces itself as a true global player,with all the attendant implications for the share price. A very strong buy whilst the SP languishes below 10 pence.imo.

Going global !! http://byopet.co.uk/ clogheen, the first of some increasingly aggressive upward moves in the Byotrol SP, imo.